

Innate immunity is the most broadly effective host defense, being essential to clear the majority of microbial infections. Scavenger Receptors comprise a family of sensors expressed in a multitude of host cells, whose dual role during microbial pathogenesis gained importance over recent years. SRs regulate the recruitment of immune cells and control both host inflammatory response and bacterial load. In turn, pathogens have evolved different strategies to overcome immune response, avoid recognition by SRs and exploit them to favor infection. Here, we discuss the most relevant findings regarding the interplay between SRs and pathogens, discussing how these multifunctional proteins recognize a panoply of ligands and act as bacterial phagocytic receptors. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
| EMTREE drug terms: | CD206 receptorCD36 antigenCXCL16 chemokinedectin 1LOX 1 receptorMARCO receptorscavenger receptorscavenger receptor Ascavenger receptor BSREC receptorstabilin 1unclassified drugscavenger receptor |
|---|---|
| EMTREE medical terms: | humanmicrobiologynonhumanpathogenesispriority journalReviewanimalbacterial infectionbacterial phenomena and functionsbacteriumgeneticsimmunologyinnate immunitymicrobiologypathogenicity |
| MeSH: | AnimalsBacteriaBacterial InfectionsBacterial Physiological PhenomenaHumansImmunity, InnateReceptors, Scavenger |
Receptors, Scavenger
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Programa Operacional Temático Factores de Competitividade | ||
| Fundação para a Ciência e a Tecnologia See opportunities | ||
| European Regional Development Fund | ||
| NORTE 2020 | ||
| Federación Española de Enfermedades Raras |
This work received funding from Norte-01–0145-FEDER-000012 – Structured program on bioengineered therapies for infectious diseases and tissue regeneration, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL Partnership Agreement, through the European Regional Development Fund (FEDER). R.P received an FCT Doctoral Fellowship [SFRH/BD/89542/2012] through FCT/MEC co-funded by QREN and POPH (Programa Operacional Potencial Humano). SS was supported by FCT Investigator program (COMPETE, POPH, and FCT).
Cabanes, D.; Instituto de Investigação e Inovação em Saúde (i3S), Group of Molecular Microbiology, Universidade do Porto, Rua Alfredo Allen, 208, Porto, Portugal;
© Copyright 2019 Elsevier B.V., All rights reserved.